Identification of Immunomodulators Associated With Atrial Fibrillation Reporting: Analysis of the WHO Pharmacovigilance Database

Conditions: Atrial Fibrillation Interventions: Drug: Immunomodulators with FDA approval on the 1st January 2023. Sponsors: University Hospital, Caen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials